Sevelamer for Reducing Endotoxemia and Immune Activation

This study has been completed.

Sponsor:

Collaborator:

Information provided by (Responsible Party):

AIDS Clinical Trials Group

ClinicalTrials.gov Identifier:

NCT01543958

First received: February 29, 2012

Last updated: June 7, 2013

Last verified: June 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2012
Primary Completion Date:	September 2012 (Final data collection date for primary outcome measure)